Crystal Shereen Denlinger
Fox Chase Cancer Center · 237 works · 12,343 citations · h-index 45
Top works
- KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
- Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
- Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- Esophageal and Esophagogastric Junction Cancers, Version 1.2015
- Gastric Cancer, Version 2.2013
- American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control
- Esophageal and Esophagogastric Junction Cancers
- Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
- The Challenges of Colorectal Cancer Survivorship
- Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
- Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma
- Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
- Gastric Cancer
- Senior Adult Oncology
- Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
- Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop
- Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- Survivorship: Introduction and Definition
- Weight management and physical activity throughout the cancer care continuum
- Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer